Early access
Sign in
Taking people in GermanyPhase 1

Testing an Inhaled Investigational Drug in Healthy People and Those With COPD

Tests an inhaled investigational drug in healthy adults and adults with COPD.

Key facts

Who runs it
Genentech Inc.
Where
Berlin and Hanover, GermanySee the 2 sites
Registry title
A Study to Evaluate the Safety and Activity of an Inhaled Investigational Drug (RO7616605) in Healthy Volunteers and Participants With COPD
Status
Recruiting
Phase
Phase 1
People taking part
104 people, planned
Started
27 Aug 2026
Expected to end
13 Sept 2029
Type of study
Interventional
Record updated
24 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for healthy volunteers and people with COPD to test the safety and activity of an inhaled investigational drug, RO7616605.

Age
18 years or older
Sex
All sexes can join.

Where in Germany

  • Charite Research Organisation GmbHBerlin, GermanyTaking people
  • The Fraunhofer Institute For Toxicology And Experimental Medicine ITEMHanover, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Testing an Inhaled Investigational Drug in Healthy People and Those With COPDGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
24 August 2026